Tebchaws Meskas Tuaj Tebchaws, Tebchaws Thoob Plaws Hauv Tebchaws Asmeskas, Lub Tebchaws Thoob Plaws Tebchaws Thoob Plaws Tebchaws

Apatinib (811803-05-1)

Rating:
5.00 tawm ntawm 5 raws li nyob rau 1 neeg ntsuam xyuas
SKU: 811803-05-1. Qeb:

AASraw yog nrog synthesis thiab muaj peev xwm ua tau los ntawm cov gram los ntawm huab hwm coj ntawm Apatinib (CAS 811803-05-1), raws li CGMP kev tswj thiab kev tswj cov kev tswj qhov system.

Apatinib, ib qho tshiab tis tsawg tis tsawg tyrosine kinase inhibitor uas inhibits vascular endothelial loj hlob tau receptor-2, tau txais kev tso cai rau kev noj tshuaj hu ua metastatic gastric adenocarcinoma hauv Suav teb hauv Oct 2014. Qhov no yog thawj daim ntawv tshaj tawm qhia txog kev siv cov kab mob cancer colon cancer uas yog ib hom kev kho thib peb rau hnub.

AASRAW hmoov PDF Icon

Hauj lwm yam khoom

Apatinib video


Apatinib yooj yim Cim

Lub npe: Apatinib
CAS: 811803-05-1
Molecular Formula: C24H23N5O
Molecular phaus: 397.47232
Melt Point: 111-114 ° C
Cia Temp: -20 ° C
xim: Daj daj daj kom daj


Apatinib (811803-05-1) kev siv nyob rau hauv kev hloov thev taus

npe

Apatinib (CAS 811803-05-1), los yog YN968D1, Mesylate.

Apatinib Pab

Cov neeg mob kheesxaws raug coj los siv ntau hom tshuaj Apatinib txhua hnub rau 28 hnub. Apatinib tau noj qab nyob zoo tom qab txhaj koob tshuaj 750 mg / hnub, 3 ntawm 3 koob tshuaj limiting toxicities tau tshaj tawm ntawm 1000 mg / hnub thiab cov tshuaj tiv thaiv kab mob siab tshaj plaws yog txiav txim siab mus rau XYUMX mg / hnub.

Ceeb toom rau Apatinib

Koj yuav tsum paub cov kev mob tshwm sim thaum koj noj cov tshuaj Apatinib. Cov kev mob tshwm sim feem ntau ntawm apinalib yog mob siab thiab mob tes taw; txawm li ntawd los, qhov tshuaj lom ntawm apinalib yog controllable thiab tolerable.

Cov lus qhia ntxiv

Rivoceranib (Apatinib, YN968D1) yog ib qho kev sib tw tshuaj kws kho mob uas tau tsim tawm sab nraud ntawm Tuam Tshoj los ntawm LSK BioPharma, rau kev kho cov qog nqaij hlav xws li mob siab lossis mob metastatic gastric cancer, colonectal cancer, thiab hepatocellular carcinoma. YN968D1 yog thawj zaug ua ke thiab patented los ntawm Advenchen Laboratories hauv Southern California. Apatinib yog tam sim no kev ua lag luam hauv Suav teb rau kev mob plab mog siab heev los ntawm Suav-daim ntawv tso cai-tuav nrog, Jiangsu Hengrui MedicineCo., Ltd raws li cov lag luam npe Aitan®. LSK BioPharma tuav lub ntiaj teb txoj cai (suav Tuam Tshoj) thiab tau koom tes rau txoj kev loj hlob thiab kev lag luam ntawm rivoceranibin South Kauslim.

Rivoceranib yog ib qho kev ua kom muaj zog hauv tus neeg tsim kab mob qog cov leeg txhim khu qhov hnyuv-2 (hu ua VEGFR2) uas kho cov thawj txoj hauv kev rau mob qog-mediatedangiogenesis. Nws tau raug clinically kuaj nyob rau hauv ntau tshaj 1,000 cov neeg mob thoob ntiaj teb thiab hasdemonstrated ua tau zoo nyob rau hauv ntau cov qog nqaij hlav xws li gastric cancer, colourectal cancer, hepatocellular carcinoma, mob qog cell tsis muaj mob ntsws cancer, esophageal cancer, thyroidcancer, mesothelioma, thiab hlav neuroendocrine. Nws kuj tau pom tias cov kev muaj peev xwm tuaj yeem ua kom cov txiaj ntsim tau zoo ua ke nrog cov kws kho mob thiab cov tshuaj tiv thaiv kab mob, nrog rau kev kho tu tsev.


Yuav ua li cas yuav Apatinib los ntawm AASraw

1.To tiv tauj peb ntawm peb tus email nug qhov system, lossis hauv internettus sawv cev rau tus neeg sawv cev (CSR).
2.To muab peb nug koj qhov ntau thiab qhov chaw nyob.
3.Our CSR yuav muab nqe lus hais txog koj, qhov them nqi, tus lej nrhiav, kev xaib thiab kwv yees hnub uas tuaj txog (ETA).
4.Payment ua tiav thiab cov khoom xa tuaj rau 12 cov xuab moos (Rau kev txiav txim hauv 10kg).
5.Goods tau txais thiab muab tswv yim.

PRECAUTION THIAB DISCLAIMER:

Cov Khoom Siv No Yog Muag Rau Kev Tshawb Xyuas Siv Xwb. Cov ntsiab lus ntawm kev muag khoom Thov. Tsis Yog Rau Tib Neeg Noj, Tsis Kho Mob, Kho Tsiaj, lossis Tsev Neeg Siv.


COA

HNMR

Zaub mov txawv

References & cov khoom citations